Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity
The antiparasitic drug nitazoxanide (NTZ) has received considerable attention for its potential in cancer therapy. In this study, we demonstrate that tizoxanide (TIZ), an active metabolite of NTZ, exhibits antiglioma activity in vitro and in vivo by inducing G2/M cell cycle arrest and apoptosis. In...
Saved in:
Main Authors: | Si Huang (Author), Jingxian Xiao (Author), Junyong Wu (Author), Jiayi Liu (Author), Xueping Feng (Author), Chengdong Yang (Author), Daxiong Xiang (Author), Shilin Luo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
by: Xinyan Hao, et al.
Published: (2022) -
Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
by: Wenqun Li, et al.
Published: (2018) -
Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis
by: Lei Wu, et al.
Published: (2020) -
The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan
by: Wenfeng Li, et al.
Published: (2024) -
Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines
by: Jiemin Wang, et al.
Published: (2018)